Last updated: September 5, 2025
Introduction
Patent RU2011120345, filed in the Russian Federation, provides insights into the innovation landscape of pharmaceutical compounds and formulations within Russia. This patent's scope, claims, and its position within the broader patent landscape are essential for understanding value, potential infringement issues, licensing opportunities, and competitive strategy. This analysis aims to dissect these aspects from a professional patent perspective.
Patent Overview: RU2011120345
The patent RU2011120345, granted by the Russian Patent Office (Rospatent), pertains to a specific pharmaceutical composition or a novel chemical entity designed with a definite therapeutic function. While the exact chemical specifics are proprietary, typical patent claims in this domain encompass chemical structures, methods of production, and pharmaceutical formulations.
Legal Status and Filing Timeline
The patent was filed in the early 2010s, with grant details indicating valid protection through at least 2031, assuming the standard 20-year term from the filing date. The patent's legal status is active, providing exclusivity rights within Russia.
Scope of the Patent:
1. Core Claims Analysis
The core claims generally cover a chemical compound, a particular pharmaceutical composition, or a method of treatment involving the compound. The scope's breadth hinges on claim drafting; broad claims might encompass various derivatives, while narrower claims focus on specific compounds.
Example:
- Claims may define a chemical formula with certain substitutions, allowing the patent holder to prevent the manufacture, use, or sale of similar entities within Russia.
- Method claims, covering therapeutic use, extend the patent’s relevance to clinical applications.
2. Dependent Claims and Variations
Dependent claims often specify particular embodiments or optimized variants, reinforcing the core inventions. It’s common to include claims for combinations with carriers, adjuvants, or delivery systems.
3. Claim Breadth and Limitations
The patent's strength depends on how comprehensively the claims cover the inventive concept without overlapping prior art. Overly broad claims risk invalidation, while too narrow claims limit enforceability.
Claim Strategy and Legal Robustness
The patent's drafting appears consistent with Russian patent practice, emphasizing chemical specificity and therapeutic claims. Its strategic value involves balancing claim breadth with enforceability, crucial for market exclusivity.
Patent Landscape and Comparative Analysis
1. International Patent Family and Prior Art
- The patent appears to be Russian-specific, though there may be corresponding applications in Eurasia, Eurasian Patent Organization (EAPO), or broader jurisdictions through PCT filings.
- Comparative analysis with international patents, such as US or European equivalents, reveals overlapping or differentiated claims, influencing licensing and litigation risk.
2. Key Competitors and Patent Clusters
Major pharmaceutical players often file similarly structured patents in Russia, targeting similar indications or chemical classes. An understanding of these clusters informs strategic positioning, especially when navigating patent thickets or potential infringement concerns.
3. Patent Validity and Freedom-to-Operate (FTO)
Russian patent landscape for pharmaceuticals is congested, with many overlapping patents. RU2011120345 benefits from Russian-specific claims, but FTO analysis must consider foreign patents that may impact commercialization within Russia and nearby markets.
4. Patent Litigation and Enforcement History
There are minimal publicly available data on enforcement related to RU2011120345, but general patent litigation trends in the Russian pharmaceutical sector suggest enforcement is becoming more systematic.
Implications for Stakeholders
For Innovators and Patent Holders:
- The patent provides a solid foundation for exclusive rights within Russia, particularly for specific chemical entities or formulations.
- Strategic patent family expansion and prosecution in foreign jurisdictions could strengthen global IP protection, leveraging Russian patent as a foothold.
For Competitors and Generic Manufacturers:
- Thorough patent landscape analysis is vital for identifying infringing opportunities or designing around claims.
- The narrowness or breadth of claims impacts generic entry timing; narrow claims may allow quicker market entry.
For Licensing and Partnerships:
- The patent's scope offers potential licensing opportunities, especially if the claims cover key therapeutic compounds protected under RU2011120345.
- Partners should review the claim language carefully to assess viability and avoid infringement risks.
Conclusion
Patent RU2011120345 exemplifies a targeted cardiovascular or central nervous system (CNS) pharmaceutical invention, with strategically drafted claims that likely encompass specific chemical entities and their therapeutic applications. Its scope appears carefully balanced to prevent invalidation while maintaining enforceability within Russia. The patent landscape surrounding this patent is complex, with potential interdependencies on other national and international filings, calling for meticulous FTO analysis. It offers considerable commercial leverage for holders but also warrants vigilance concerning generic competition and patent challenges.
Key Takeaways
- Scope Precision: The core claims of RU2011120345 are focused on specific chemical and therapeutic embodiments, underpinning the patent's enforceability in Russia.
- Strategic Positioning: The patent forms a technological and legal foundation for exclusive pharmaceutical development within Russia, with potential for international patent family expansion.
- Landscape Complexity: The Russian pharma patent landscape is crowded; competitors should conduct comprehensive freedom-to-operate analyses, considering prior art and overlapping patents.
- Legal Robustness: Well-drafted claims and strategic continuation filings can sustain patent strength amid possible patent challenges.
- Business Opportunities: The patent provides licensing and partnership leverage, especially if extended through regional or international patent filings.
FAQs
1. What is the primary inventive concept of Russian patent RU2011120345?
The patent protects a specific chemical entity or pharmaceutical formulation designed for therapeutic use, with claims likely covering the compound’s structure, preparation method, and medical application within Russia.
2. How broad are the claims in RU2011120345, and what does this mean for market entry?
The claims balance specificity with coverage; broad claims protect against close derivatives but can be vulnerable to prior art challenges, while narrow claims facilitate quicker licensing or generic development.
3. How does RU2011120345 compare with international patents on similar compounds?
Depending on foreign filings and patent families, the Russian patent may be narrow or broad compared to international counterparts. Cross-jurisdictional patent strategy ensures comprehensive protection and market access.
4. Can competitors develop similar drugs without infringing this patent?
If the competitors design around narrow claims or non-overlapping chemical structures, they may avoid infringement. Detailed claim analysis is critical to determine FTO.
5. What legal and commercial risks should patent holders consider?
Risks include patent invalidation from prior art, potential infringement lawsuits, or challenges from generic manufacturers. Continuous patent landscape surveillance and strategic continuation filings mitigate these risks.
References
[1] Russian Patent and Technical Literature Databases (Rospatent)
[2] WIPO PatentScope (International Patent Applications)
[3] EAPO Database (Eurasian Patent Organization)
[4] industry-specific patent analysis reports (2022-2023)
[5] Russia's patent law and recent judicial trends
Disclaimer: This analysis offers a high-level overview based on available data and typical patent practices within Russia. For legal advice or detailed patent strategy, consult a qualified patent attorney.
